Neuropathological diagnosis of PSP is based on the presence of neuronal loss, accumulation of tau protein into NFTs in neurons and astrocytes and dystrophic neurites in basal ganglia and brainstem [155,156,157,158,159] (Table 1). This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.